Autoimmune hepatitis in patients with a diagnosis of multiple sclerosis;Hepatitis autoinmune en pacientes con diagnóstico de esclerosis múltiple

Gastroenterologia y Hepatologia

Volumn 27, Issue 9, 2004, Pages 521-524

  Nunez O ^a   De Andres C ^a   Alvarez E ^a   Garcia Monzon C ^b   Clemente, G ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL UNIVERSITARIO SANTA CRISTINA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; STEROID; TACROLIMUS;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERGAMMAGLOBULINEMIA; LIVER FAILURE; LIVER TRANSPLANTATION; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; SCORING SYSTEM; STEROID THERAPY;

EID: 9744277499     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13068137     Document Type: Article

References (24)

1. Manns MP, Strassburg CP. Autoimmune hepatitis: clinical challenges. Gastroenterology 2001;120:1502-17.
2. Noseworthy JH, Lucchinetti C, Rodríguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000;343:938-52.
3. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38.
4. Compston A, Coles A. Multiple sclerosis. Lancet 2002;359: 1221-31.
5. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
6. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33:1444-52.
7. Sotgiu S, Pugliatti M, Sanna A, Sotgiu A, Castiglia P, Solinas G, et al. Multiple sclerosis complexity in selected populations: the challenge of Sardinia, insular Italy. Eur J Neurol 2002;9: 329-41.
8. Prat E, Martin R. The immunopathogenesis of multiple sclerosis. J Rehabil Res Dev 2002;39:187-99.
9. Giovannoni G, Thorpe J. Is it multiple sclerosis or not? Neurology 2001;57:1357-8.
10. De Seze J, Devos D, Castelnovo G, Labauge P, Dubucquoi S, Stoijkovic T, et al. The prevalence of Sjögren syndrome in patients with primary progressive multiple sclerosis. Neurology 2001;57:1359-63.
11. Pontecorvo MJ, Levinson JD, Roth JA. A patient with primary biliary cirrhosis and multiple sclerosis. Am J Gastroenterol 1992; 92:433-6.
12. Walther EU, Hohlfeld R. Multiple sclerosis. Side effects of interferon beta therapy and their management. Neurology 1999; 53:1622-7.
13. Durelli L, Bongioanni MR, Ferrero B, Oggero A, Marzano A, Rizzetto M. Interferon treatment for multiple sclerosis: autoimmune complications may be lethal. Neurology 1998;50:570-1.
14. Speciale L, Saresella M, Caputo D, Ruzzante S, Mancuso R, Calvo MG, et al. Serum auto antibodies presence in multiple sclerosis patients treated with beta-interferon la and lb. J Neurovirol 2000;6(Suppl 2):S57-61.
15. Yoshida EM, Rasmussen SL, Steinbrecher UP, Scudamore CH, Oger JJ. Fulminant liver failure during interferon beta treatment of multiple sclerosis. Neurology 2001;56:1416.
16. Durelli L, Ferrero B, Oggero A, Verdun E, Ghezzi A, Montanari E, et al. Liver and thyroid function and autoimmunity during interferon-β1b treatment for MS. Neurology 2001;57:1363-70.
17. Duchini A. Autoimmune hepatitis and interferon beta-1a for multiple sclerosis. Am J Gastroenterol 2002;97:767-8.
18. Núñez-Martínez O, De la Cruz G, Salcedo M, Molina J, De Diego A, Ripoll C, et al. Liver transplantation for autoimmune hepatitis: fulminant versus chronic hepatitis presentation. Transplant Proc 2003;35:1857-8.
19. Nikias GA, Batts KP, Czaja AJ. The nature and prognostic implications of autoimmune hepatitis with acute presentation. J Hepatol 1994;21:866-71.
20. Reich DJ, Fiel I, Guarrera JV, Emre S, Guy SR, Schwartz ME, et al. Liver transplantation for autoimmune hepatitis. Hepatology 2000;32:693-700.
21. Bruguera M, Caballería L, Pares A, Rodes J. Hepatitis autoinmune. Características clínicas y respuesta al tratamiento en una serie de 49 pacientes españoles. Gastroenterol Hepatol 1998;21: 375-81.
22. Piñol V, Cubiella J, Navasa M, Fernández J, Halperin I, Bruguera M, et al. Hepatitis autoinmune asociada a tiroiditis e hipofisitis. Presentación de un caso. Gastroenterol Hepatol 2000;23: 123-5.
23. Singh R, Nair S, Farr G, Mason A, Perrillo R. Acute autoimmune hepatitis presenting with centrizonal liver disease: case report and review of the literature. Am J Gastroenterol 2002;97: 2670-3.
24. Salcedo M, Vaquero J, Banares R, Rodríguez-Mahou M, Álvarez E, Vicario JL, et al. Response to steroids in de novo autoimmune hepatitis after liver transplantation. Hepatology 2002;35:349-56.